Health-care companies ticked up amid further vaccine progress.
The European Union started its rollout of vaccines with residents of German nursing homes receiving shots Saturday.
Novavax shares fell sharply after the drug developer prepared for a late-stage trial of its Covid-19 shot on roughly 30,000 volunteers in the U.S. and Mexico, becoming the fifth Covid-19 vaccine to enter final-stage testing in the U.S.
Write to Rob Curran at [email protected]
(END) Dow Jones Newswires
December 28, 2020 17:00 ET (22:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.